Literature DB >> 3729518

Vaccine advances.

J W Smith.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3729518      PMCID： PMC1777834          DOI： 10.1136/adc.61.6.531

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  12 in total

1.  Live attenuated bacterial vaccines: new approaches for safety and efficacy.

Authors:  A M Hooke; J A Bellanti; M P Oeschger
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

2.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Authors:  H Peltola; H Käyhty; M Virtanen; P H Mäkelä
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

3.  Location and primary structure of a major antigenic site for poliovirus neutralization.

Authors:  P D Minor; G C Schild; J Bootman; D M Evans; M Ferguson; P Reeve; M Spitz; G Stanway; A J Cann; R Hauptmann; L D Clarke; R C Mountford; J W Almond
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

4.  Comparative immunogenicity studies on Epstein-Barr virus membrane antigen (MA) gp340 with novel adjuvants in mice, rabbits, and cotton-top tamarins.

Authors:  A J Morgan; M A Epstein; J R North
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

5.  Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.

Authors:  G L Smith; M Mackett; B Moss
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

6.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.

Authors:  M H Wahdan; C Sérié; Y Cerisier; S Sallam; R Germanier
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

7.  Live attenuated varicella virus vaccine. Efficacy trial in healthy children.

Authors:  R E Weibel; B J Neff; B J Kuter; H A Guess; C A Rothenberger; A J Fitzgerald; K A Connor; A A McLean; M R Hilleman; E B Buynak
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

8.  Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children.

Authors:  T Vesikari; E Isolauri; A Delem; E D'Hondt; F E André; G Zissis
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

9.  Human hepatitis B vaccine from recombinant yeast.

Authors:  W J McAleer; E B Buynak; R Z Maigetter; D E Wampler; W J Miller; M R Hilleman
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

10.  Progress toward a live attenuated human hepatitis A virus vaccine.

Authors:  M R Hilleman; P J Provost; E B Buynak; A A McLean
Journal:  Dev Biol Stand       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.